Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04101656 | Accelerated Partial Irradiation of the Breast: New Altered Fractionation | unknown | — | 174 | Fundación Pública Andaluza para la gestión de la Investigación en SevillaOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT05673629 | Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer | unknown | Phase 3 | 552 | Beijing Biostar Pharmaceuticals Co., Ltd.INDUSTRY |
| 1 |
| Nov 8, 2023 |
| clinicaltrials |
| NCT06073509 | Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT(WATCH) | unknown | — | 200 | Sophie JACOBOTHER_GOV | 1 | Nov 8, 2023 | clinicaltrials |
| NCT05071911 | Targeted Axillary Dissection After Neo-adjuvant Chemotherapy | unknown | — | 100 | Universitair Ziekenhuis BrusselOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06114589 | A Study to Develop Molecular Integrated Predictive Models of Breast Radio-toxicity (Precise-RTox)((Precise-RTox)) | unknown | — | 420 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06112977 | Restore-B: A Trial Comparing Prepectoral Implant-based Breast Reconstruction With and Without Mesh | unknown | N/A | 40 | University of OxfordOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT03374826 | PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients | unknown | N/A | 125 | Maastricht University Medical CenterOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT06106711 | The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).(EVA) | unknown | — | 92 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Oct 30, 2023 | clinicaltrials |
| NCT06107894 | TIL Therapy for Patients With Advanced Solid Tumors | unknown | Phase 1 | 12 | NeogenTCINDUSTRY | 0 | Oct 30, 2023 | clinicaltrials |
| NCT06097546 | Serum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast Cancer | unknown | — | 90 | Assiut UniversityOTHER | 0 | Oct 24, 2023 | clinicaltrials |
| NCT05406531 | The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors | unknown | N/A | 440 | Masaryk UniversityOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT05498597 | AMT-151 in Patients With Selected Advanced Solid Tumours | unknown | Phase 1 | 30 | Multitude Therapeutics Inc.INDUSTRY | 2 | Oct 19, 2023 | clinicaltrials |
| NCT03129139 | A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors(Minnelide 101) | unknown | Phase 1 | 66 | Minneamrita Therapeutics LLCINDUSTRY | 1 | Oct 18, 2023 | clinicaltrials |
| NCT06088056 | A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases | unknown | Phase 2 | 17 | Fudan UniversityOTHER | 1 | Oct 18, 2023 | clinicaltrials |
| NCT06088719 | Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence | unknown | — | 300 | KK Women's and Children's HospitalOTHER_GOV | 1 | Oct 18, 2023 | clinicaltrials |
| NCT01513408 | Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy(PRIMUNEO) | unknown | N/A | 500 | Centre Georges Francois LeclercOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT05144867 | Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Breast Cancer With Brain Oligometastasis(SRSvsWBRT) | unknown | Phase 3 | 98 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT04267315 | Trigger Point Injections for Post-Mastectomy Pain Syndrome | unknown | Phase 2 | 72 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT06080620 | The Choice of Treatment Methods and Efficacy of LABC | unknown | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT06065592 | Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms(CAT_PB) | unknown | Phase 1 | 500 | Lebanese UniversityOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06070324 | Effect of Suture Material on Postoperative Nipple Areolar Complex Widening | unknown | N/A | 180 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 0 | Oct 6, 2023 | clinicaltrials |
| NCT04832594 | Using AI to Select Women for Supplemental MRI in Breast Cancer Screening(ScreenTrustMRI) | unknown | N/A | 2,500 | Karolinska University HospitalOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT04591431 | The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy(ROME) | unknown | Phase 2 | 400 | Fondazione per la Medicina PersonalizzataOTHER | 1 | Oct 3, 2023 | clinicaltrials |
| NCT01560663 | Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer | unknown | — | 415 | Miguel Martín JiménezOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT05912062 | Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer(BiOnHER) | unknown | — | 80 | Institut Català d'OncologiaOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT06061666 | Treatment of Insomnia in Patients With Breast Cancer | unknown | N/A | 80 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT06061835 | Non-contrast Magnetic Resonance Angiography in Deep Inferior Epigastric Perforator Flap Breast Reconstruction Planning | unknown | N/A | 135 | I.M. Sechenov First Moscow State Medical UniversityOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT03382340 | IMX-110 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 70 | Immix Biopharma Australia Pty LtdINDUSTRY | 2 | Sep 28, 2023 | clinicaltrials |
| NCT04883814 | 18F-fluoroestradiol (FES) PET/CT for Breast Cancer | unknown | Phase 2 | 124 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05024591 | Artificial Intelligence for breaST canceR scrEening in mAMmography (AI-STREAM) | unknown | — | 25,008 | Kyung Hee University Hospital at GangdongOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05174832 | Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients | unknown | Phase 2 | 136 | Fudan UniversityOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05800834 | Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds(MorphineGEL) | unknown | Phase 2 | 106 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Sep 28, 2023 | clinicaltrials |
| NCT06001528 | Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer | unknown | — | 2,400 | Shantou Central HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT03983577 | Efficacy of Point Of Service Testing in MBC(EPOST MBC) | unknown | N/A | 100 | University of Kansas Medical CenterOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT05296577 | Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer | unknown | Phase 2 | 134 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 25, 2023 | clinicaltrials |
| NCT06052085 | Investigation of the Efficiency of Pain Neuroscience Education in Patients With Chronic Pain After Breast Cancer Surgery | unknown | N/A | 50 | Hacettepe UniversityOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT03712956 | CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER | unknown | Phase 2 | 63 | European Institute of OncologyOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT04165993 | Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer | unknown | Phase 2 | 68 | Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06046664 | Oncotype DX DCIS: Impact on Radiotherapy Decision Making(ONCOTYPE) | unknown | N/A | 78 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06046755 | Nutritional Intervention-induced Weight Loss During the Oncological Treatment of Obesity-related Breast Cancer(NUTOBREST) | unknown | N/A | 220 | Hospital Clinico Universitario de SantiagoOTHER | 0 | Sep 21, 2023 | clinicaltrials |
| NCT06040983 | Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing | unknown | N/A | 30 | China Medical University HospitalOTHER | 0 | Sep 18, 2023 | clinicaltrials |
| NCT05353361 | A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer | unknown | Phase 2 | 402 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Sep 15, 2023 | clinicaltrials |
| NCT05823623 | Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer | unknown | Phase 2 | 30 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT06010615 | Relative Dose Intensity of Adjuvant Chemotherapy in Older Women With ER+ HER2- Breast Cancer.(BREASTOLD) | unknown | — | 70 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Sep 7, 2023 | clinicaltrials |
| NCT05755048 | FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 3 | 314 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY | 1 | Sep 1, 2023 | clinicaltrials |
| NCT06015126 | Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients | unknown | N/A | 60 | Yan XueOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT05125991 | Evaluation of the Effectiveness of Prepectoral Breast Reconstruction | unknown | N/A | 58 | European Institute of OncologyOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT05923164 | Reliability And Validity Study Of "The Evaluation Tool For Myofascial Adhesions In Patients After Breast Cancer" In Turkish Language(MAP-BC) | unknown | — | 88 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT06000033 | Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative, HER2-Low-Expressing Metastatic Breast Cancer | unknown | Phase 2 | 35 | Qilu Hospital of Shandong UniversityOTHER | 0 | Aug 21, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Nov 8, 2023source: clinicaltrials